| Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation H Huang, H Weng, W Sun, X Qin, H Shi, H Wu, BS Zhao, A Mesquita, ... Nature cell biology 20 (3), 285-295, 2018 | 2366 | 2018 |
| R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling R Su, L Dong, C Li, S Nachtergaele, M Wunderlich, Y Qing, X Deng, ... Cell 172 (1), 90-105. e23, 2018 | 986 | 2018 |
| METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification H Weng, H Huang, H Wu, X Qin, BS Zhao, L Dong, H Shi, J Skibbe, ... Cell stem cell 22 (2), 191-205. e9, 2018 | 889 | 2018 |
| RNA N6-methyladenosine modification in cancers: current status and perspectives X Deng, R Su, H Weng, H Huang, Z Li, J Chen Cell research 28 (5), 507-517, 2018 | 688 | 2018 |
| Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally H Huang, H Weng, K Zhou, T Wu, BS Zhao, M Sun, Z Chen, X Deng, ... Nature 567 (7748), 414-419, 2019 | 588 | 2019 |
| Targeting FTO suppresses cancer stem cell maintenance and immune evasion R Su, L Dong, Y Li, M Gao, L Han, M Wunderlich, X Deng, H Li, Y Huang, ... Cancer cell 38 (1), 79-96. e11, 2020 | 585 | 2020 |
| RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia C Shen, Y Sheng, AC Zhu, S Robinson, X Jiang, L Dong, H Chen, R Su, ... Cell stem cell 27 (1), 64-80. e9, 2020 | 321 | 2020 |
| R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis Y Qing, L Dong, L Gao, C Li, Y Li, L Han, E Prince, B Tan, X Deng, ... Molecular cell 81 (5), 922-939. e9, 2021 | 244 | 2021 |
| METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis R Su, L Dong, Y Li, M Gao, PC He, W Liu, J Wei, Z Zhao, L Gao, L Han, ... Nature cell biology 24 (2), 205-216, 2022 | 223 | 2022 |
| Role of N6-methyladenosine modification in cancer X Deng, R Su, X Feng, M Wei, J Chen Current opinion in genetics & development 48, 1-7, 2018 | 208 | 2018 |
| The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia H Weng, F Huang, Z Yu, Z Chen, E Prince, Y Kang, K Zhou, W Li, J Hu, ... Cancer Cell 40 (12), 1566-1582. e10, 2022 | 160 | 2022 |
| The roles and implications of RNA m6A modification in cancer X Deng, Y Qing, D Horne, H Huang, J Chen Nature Reviews Clinical Oncology 20 (8), 507-526, 2023 | 149 | 2023 |
| Critical enzymatic functions of FTO in obesity and cancer X Deng, R Su, S Stanford, J Chen Frontiers in endocrinology 9, 396, 2018 | 140 | 2018 |
| FTO in cancer: functions, molecular mechanisms, and therapeutic implications Y Li, R Su, X Deng, Y Chen, J Chen Trends in cancer 8 (7), 598-614, 2022 | 134 | 2022 |
| Cancer precision medicine: from cancer screening to drug selection and personalized immunotherapy X Deng, Y Nakamura Trends in pharmacological sciences 38 (1), 15-24, 2017 | 94 | 2017 |
| RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer W Li, X Deng, J Chen Seminars in cancer biology 86, 664-677, 2022 | 80 | 2022 |
| RNA modifications in cancer: functions, mechanisms, and therapeutic implications H Huang, H Weng, X Deng, J Chen Annual Review of Cancer Biology 4 (1), 221-240, 2020 | 80 | 2020 |
| METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism L Han, L Dong, K Leung, Z Zhao, Y Li, L Gao, Z Chen, J Xue, Y Qing, W Li, ... Cell Stem Cell 30 (1), 52-68. e13, 2023 | 76 | 2023 |
| QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism Z Zhao, Y Qing, L Dong, L Han, D Wu, Y Li, W Li, J Xue, K Zhou, M Sun, ... Cell 186 (15), 3208-3226. e27, 2023 | 69 | 2023 |
| Impact of temperature exposure on stability of drugs in a real-world out-of-hospital setting S De Winter, P Vanbrabant, NTT Vi, X Deng, I Spriet, A Van Schepdael, ... Annals of emergency medicine 62 (4), 380-387. e1, 2013 | 67 | 2013 |
Yusuke NakamuraNIBIOHN, JFCR, U of Chicago, U of Tokyo, RIKEN, Cancer Institute, Univ. of Utah, Osaka UnivZweryfikowany adres z jfcr.or.jp